Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-041401

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lonnel Coats
Officer — President and CEO · Director
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$8.20Feb 11, 2016A134,230A—Feb 11, 2026Common Stock134,230134,230D
Restricted Stock Units (Phantom Stock)F2,F3—Feb 11, 2016A33,560A——Common Stock33,56033,560D
Stock Option (Right to Buy)F4$11.76holding————Jul 7, 2024Common Stock121,928121,928D
Stock Option (Right to Buy)F5$6.23holding————Feb 5, 2025Common Stock173,371173,371D
Restricted Stock Units (Phantom Stock)F2,F6—holding—————Common Stock43,34243,342D

Explanation of responses